Xinjun Wang
Impact in
- Genetics top 10%
- Glioma Diagnosis and Treatment
Papers in
- Co-authors
- Shaolong Zhou (17 shared papers)Wulong Liang (14 shared papers)Xudong Fu (12 shared papers)Lu-Bin Lan (1 shared paper)Francesca‐Fang Liao (1 shared paper)Junming Yue (1 shared paper)Santosh Kumar (1 shared paper)Jing Jing Li (1 shared paper)
- Journals
- Journal of neurosurgery (3 papers)Frontiers in Oncology (3 papers)Biomedicine & Pharmacotherapy (3 papers)International Journal of Nanomedicine (2 papers)Molecular Biology Reports (2 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Xinjun Wang
61 papers receiving 937 citations
Peers
Comparison fields: 5 of 87
- Genetics 116
- Drug Discovery 3
- Cancer Research 118
- Neurology 62
- Molecular Biology 318
Countries citing papers authored by Xinjun Wang
This map shows the geographic impact of Xinjun Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinjun Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinjun Wang more than expected).
Fields of papers citing papers by Xinjun Wang
This network shows the impact of papers produced by Xinjun Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinjun Wang. The network helps show where Xinjun Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Xinjun Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 65 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 187 | |
| 2 | 2019 | 52 | |
| 3 | 2022 | 48 | |
| 4 | 2021 | 42 | |
| 5 | 2005 | 34 | |
| 6 | 2020 | 34 | |
| 7 | 2021 | 29 | |
| 8 | 2015 | 28 | |
| 9 | 2020 | 26 | |
| 10 | 2020 | 24 | |
| 11 | 2017 | 23 | |
| 12 | 2022 | 22 | |
| 13 | 2024 | 22 | |
| 14 | 2021 | 20 | |
| 15 | 2021 | 20 | |
| 16 | 2022 | 19 | |
| 17 | 2022 | 17 | |
| 18 | 2019 | 16 | |
| 19 | 2022 | 16 | |
| 20 | 2018 | 15 |
About Xinjun Wang
Xinjun Wang is a scholar working on Genetics, Neurology, Cancer Research, Oncology and Biomaterials, having authored 65 papers that have together received 955 indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (14 papers), Nanoparticle-Based Drug Delivery (4 papers), Extracellular vesicles in disease (4 papers), Cancer-related molecular mechanisms research (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Ubiquitin and proteasome pathways (3 papers), Cytokine Signaling Pathways and Interactions (3 papers) and Traumatic Brain Injury Research (3 papers). The work is most often cited by research in Genetics (116 citations), Drug Discovery (3 citations), Cancer Research (118 citations), Neurology (62 citations) and Molecular Biology (318 citations). Xinjun Wang has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Shaolong Zhou, Wulong Liang, Xudong Fu, Lu-Bin Lan, Francesca‐Fang Liao, Junming Yue, Santosh Kumar, Jing Jing Li, Eun‐Hee Kim and Benjamin J. Patters. Their work appears in journals such as Journal of neurosurgery, Frontiers in Oncology, Biomedicine & Pharmacotherapy, International Journal of Nanomedicine and Molecular Biology Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.